Search Results - "Carrara, C."

Refine Results
  1. 1

    TriTECM: A tetrafunctional T-cell engaging antibody with built-in risk mitigation of cytokine release syndrome by Carrara, Stefania C., Harwardt, Julia, Grzeschik, Julius, Hock, Björn, Kolmar, Harald

    Published in Frontiers in immunology (10-11-2022)
    “…Harnessing the innate power of T cells for therapeutic benefit has seen many shortcomings due to cytotoxicity in the past, but still remains a very attractive…”
    Get full text
    Journal Article
  2. 2

    Design of a Trispecific Checkpoint Inhibitor and Natural Killer Cell Engager Based on a 2 + 1 Common Light Chain Antibody Architecture by Bogen, Jan P, Carrara, Stefania C, Fiebig, David, Grzeschik, Julius, Hock, Björn, Kolmar, Harald

    Published in Frontiers in immunology (10-05-2021)
    “…Natural killer cell engagers gained enormous interest in recent years due to their potent anti-tumor activity and favorable safety profile. Simultaneously,…”
    Get full text
    Journal Article
  3. 3

    Targeted Phagocytosis Induction for Cancer Immunotherapy via Bispecific MerTK-Engaging Antibodies by Carrara, Stefania C, Bogen, Jan P, Fiebig, David, Grzeschik, Julius, Hock, Björn, Kolmar, Harald

    “…The Tyro, Axl, and MerTK receptors (TAMRs) play a significant role in the clearance of apoptotic cells. In this work, the spotlight was set on MerTK, as it is…”
    Get full text
    Journal Article
  4. 4

    Expeditious Generation of Biparatopic Common Light Chain Antibodies via Chicken Immunization and Yeast Display Screening by Bogen, Jan P, Carrara, Stefania C, Fiebig, David, Grzeschik, Julius, Hock, Björn, Kolmar, Harald

    Published in Frontiers in immunology (23-12-2020)
    “…Bispecific (BsAb) and biparatopic (BpAb) antibodies emerged as promising formats for therapeutic biologics exhibiting tailor-made functional properties. Over…”
    Get full text
    Journal Article
  5. 5

    Generation of a symmetrical trispecific NK cell engager based on a two-in-one antibody by Harwardt, Julia, Carrara, Stefania C, Bogen, Jan P, Schoenfeld, Katrin, Grzeschik, Julius, Hock, Björn, Kolmar, Harald

    Published in Frontiers in immunology (04-04-2023)
    “…To construct a trispecific IgG-like antibody at least three different binding moieties need to be combined, which results in a complex architecture and…”
    Get full text
    Journal Article
  6. 6
  7. 7

    A Generic Strategy to Generate Bifunctional Two-in-One Antibodies by Chicken Immunization by Harwardt, Julia, Bogen, Jan P, Carrara, Stefania C, Ulitzka, Michael, Grzeschik, Julius, Hock, Björn, Kolmar, Harald

    Published in Frontiers in immunology (11-04-2022)
    “…Various formats of bispecific antibodies exist, among them Two-in-One antibodies in which each Fab arm can bind to two different antigens. Their IgG-like…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Sleep spindle and slow wave activity in Bipolar Disorder: preliminary observations from a high–density EEG study by Sanguineti, C., Donati, F. L., Sala, M., Carrara, C., Casetta, C., Zangani, C., Mayeli, A., Castelnovo, A., Canevini, M. P., D’Agostino, A.

    Published in European psychiatry (19-07-2023)
    “…Introduction Recent research on Schizophrenia (SCZ) suggests that reduced sleep spindle and slow wave density could be particularly informative of underlying…”
    Get full text
    Journal Article
  10. 10

    Across-surface distances after one- and two-stage palatoplasty in children with oral cleft by Ambrosio, E C P, Bergamo, M T O P, Sforza, C, Carrara, C F C, Machado, M A A M, Oliveira, T M

    “…The goal of this study was to digitally evaluate the development of maxillary dental arches of children with unilateral cleft lip and palate treated with one-…”
    Get full text
    Journal Article
  11. 11

    Recombinant Antibody Production Using a Dual-Promoter Single Plasmid System by Carrara, Stefania C., Fiebig, David, Bogen, Jan P., Grzeschik, Julius, Hock, Björn, Kolmar, Harald

    Published in Antibodies (Basel) (13-05-2021)
    “…Monoclonal antibodies (mAbs) have demonstrated tremendous effects on the treatment of various disease indications and remain the fastest growing class of…”
    Get full text
    Journal Article
  12. 12

    3D topographies promote macrophage M2d-Subset differentiation by Carrara, Stefania C., Davila-Lezama, Amanda, Cabriel, Clément, Berenschot, Erwin J.W., Krol, Silke, Gardeniers, J.G.E., Izeddin, Ignacio, Kolmar, Harald, Susarrey-Arce, Arturo

    Published in Materials today bio (01-02-2024)
    “…In vitro cellular models denote a crucial part of drug discovery programs as they aid in identifying successful drug candidates based on their initial efficacy…”
    Get full text
    Journal Article
  13. 13

    Streamlining the Transition From Yeast Surface Display of Antibody Fragment Immune Libraries to the Production as IgG Format in Mammalian Cells by Fiebig, David, Bogen, Jan P, Carrara, Stefania C, Deweid, Lukas, Zielonka, Stefan, Grzeschik, Julius, Hock, Björn, Kolmar, Harald

    “…Yeast-surface display (YSD) is commonly applied to screen Fab immune or naïve libraries for binders of predefined target molecules. However, reformatting of…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Mimicking the immunosuppressive impact of fibroblasts in a 3D multicellular spheroid model by Grotz, Melanie, van Gijzel, Lieke, Bitsch, Peter, Carrara, Stefania C., Kolmar, Harald, Garg, Sakshi

    Published in Frontiers in drug discovery (26-07-2024)
    “…Targeting the tumor microenvironment (TME) is an attractive strategy for cancer therapy, as tumor cells in vivo are surrounded by many different influential…”
    Get full text
    Journal Article
  17. 17
  18. 18

    From cell line development to the formulated drug product: The art of manufacturing therapeutic monoclonal antibodies by Carrara, Stefania C., Ulitzka, Michael, Grzeschik, Julius, Kornmann, Henri, Hock, Björn, Kolmar, Harald

    Published in International journal of pharmaceutics (01-02-2021)
    “…Created with Biorender.com. [Display omitted] Therapeutic monoclonal antibodies and related products have steadily grown to become the dominant product class…”
    Get full text
    Journal Article
  19. 19

    A stable, novel catalyst improves hydrogen production in a membrane reactor by Irusta, S., Múnera, J., Carrara, C., Lombardo, E.A., Cornaglia, L.M.

    Published in Applied catalysis. A, General (22-06-2005)
    “…The dry reforming of methane as a source of H 2 was performed using a well-known catalyst, Rh/La 2O 3, together with a novel one, Rh/La 2O 3-SiO 2, in a…”
    Get full text
    Journal Article
  20. 20

    Preschool Pain Management Program for Young Children with Sickle Cell Disease: A Pre–Post Feasibility Study by Johnston, Julia D, Schatz, Jeffrey, Bills, Sarah E, Frye, Bridgett G, Carrara, Gabriela C

    Published in Journal of pediatric psychology (20-04-2023)
    “…Abstract Objective Vaso-occlusive pain crises in sickle cell disease (SCD) often begin in early childhood. We developed an online pain management intervention…”
    Get full text
    Journal Article